Skip Navigation Archive: U.S. Department of Health and Human Services www.hhs.gov
Archive: Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
Performance Budget Submission for Congressional Justification

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.


Exhibit W. Changes & Improvements over the Previous Year

AHRQ continues to align its portfolios to each budget line and our strategic goals as well as departmental initiatives of importance. We conducted an off-site for portfolio team members to review, revise, and develop outcome measures. The table below presents a brief statement about changes resulting from the off-site. AHRQ believes this is an iterative process and we anticipate further changes as we proceed to review our investments and their impact.

Portfolio of Work FY2005/FY2006 Measure Improvements
Quality/Safety of Patient Care Portfolio Measures remained the same with the addition of a quality measure to maintain vigilance.
Health Information Technology Portfolio Measures now address key outcomes related to Computerized Physician Order Entry (CPOE) and medication error rate, Personal Electronic Health Records, and Engineered Clinical Knowledge.
Data Development Portfolio Measures adjusted to address gaps in disease outcomes of significant importance to care management to include diabetes, coronary heart disease, and asthma.
Care Management Portfolio Measures adjusted in wording but still directed at adoption and delivery of evidence based clinical prevention services.
Cost, Organization and Socio-Economics Portfolio Measures remained the same.
Pharmaceutical Outcomes Portfolio Measures adjusted to address gaps in pharmaceutical outcomes of significant importance to include congestive heart failure, antibiotic overuse in children, and upper gastrointestinal bleeding. These changes are based on the PART review.
Training Portfolio Measures enhanced to include more focused agenda for capacity building activities.
Long-term Care Portfolio Measures expanded to address improved quality and safety, community-based care, coordination of long-term care, and consumer information.
Bioterrorism Portfolio Measures remained the same.
Organizational Support Measures remained the same.

Return to Exhibits
Proceed to Exhibit X

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care